I don't recall what was shown, but, hope they don't make an attempt to uplist before this is trading well above $10.  Uplisting is quite often a bummer for early shareholders if a company attempts it too soon.  Kevetrin and prurisol either work or they don't.   The stock will skyrocket once it is shown to work.  With or without an uplisting.